9.2008: Epitopix, LLC is proud to annouce the completion of their new facility on the MinnWest Campus. The project included the renovation of a commercial cottage to create 6,000 square feet of research & development laboratory space, administrative office space and a small scale pilot plant.

Epitopix will utilize their new space for discovery, research, and development of new vaccines. This site will house approximately 12 scientists initially, but is expected to grow to thirty or more in the coming years. In addition, Epitopix is planning to build a new vaccine manufacturing plant near the R&D laboratory which could employ an additional 100 employees or more.

Epitopix discovers and develops original veterinary vaccines to improve animal health and food safety. Epitopix vaccines are based on a novel process called SRP® Technology, discovered and patented by Epitopix microbiologists. These vaccines offer a revolutionary way to prevent bacterial diseases in livestock and poultry.